In Episode 28, Miroslav Gasparek, Sensible; Lizzy Lawrence, STAT; and Joe Lewis, Deloitte, go behind the headlines.
Frank Romanski of Lonza Capsugel dives into the excipient side of manufacturing and the emerging prevalence of digitalization ...
Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...
CPHI Frankfurt 2025 highlighted a pharmaceutical industry in flux, navigating the rapid acceleration of artificial ...
Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...
Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...
Andy Studna is an assistant editor for Pharmaceutical Executive and Applied Clinical Trials. He can be reached at [email protected].
End-to-end CDMO services simplify drug development for small biopharma companies, reducing complexity, time, and costs while ...
Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...
The Critical Medicines Act (CMA) addresses supply chain vulnerabilities by redefining procurement criteria, emphasizing quality, security, and environmental standards. European manufacturers gain ...
Darrin Lang is CEO, LABUR. Larry Egan is Vice President of Strategic Technologies, Alnylam Pharmaceuticals Inc.
In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback